Skip to content

Clinical Efficacy of Buzhong Yiqi Decoction in Patients with Gastric Cancer Chemotherapy and Its Mechanism of Regulating Immunity

Clinical Efficacy of Buzhong Yiqi Decoction in Patients with Gastric Cancer Chemotherapy and Its Mechanism of Regulating Immunity

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026993
Enrollment
Unknown
Registered
2019-10-28
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Sponsors

Jiangsu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Histologically or cytologically confirmed gastric cancer; 2. TCM syndrome type belongs to spleen and stomach qi deficiency; 3. Aged 18-80 years, physical condition is good, ECOG <= 2 points; 4. Expected survival time is more than 3 months; 5. It meets the indications and basic requirements of chemotherapy, including: the peripheral blood image is basically normal, the functions of the heart, liver, kidney and other important organs are not obviously abnormal, the electrocardiogram is basically normal, and there is no unhealed wound on the body; 6. Volunteer to participate in the study, with good compliance, able to cooperate with experimental observation, and sign the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who cannot oral administration (including digestive tract obstruction, jejunostomy);; 2. Patients who are allergic to experimental drugs; 3. Patients with serious cardiovascular, liver, kidney and blood system diseases; 4. Brain metastasis or suffering from a mentally ill person; 5. Patients participating in other clinical trials; 6. Patients with poor compliance.

Design outcomes

Primary

MeasureTime frame
improvement of quality of life;

Secondary

MeasureTime frame
T cells in peripheral blood;Cytokine;

Countries

China

Contacts

Public ContactMin Chen

Jiangsu Provincial Hospital of Traditional Chinese Medicine

sunqingminnjmu@163.com+86 18013923887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026